No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Assertio Therapeutics Announces Leadership Changes and Board Addition
Express News | Assertio Holdings, Inc. Appoints Mark Reisenauer to Its Board of Directors
Press Release: Assertio Holdings, Inc. Appoints Mark Reisenauer to Its Board of Directors
H.C. Wainwright Maintains Assertio(ASRT.US) With Buy Rating, Maintains Target Price $4
HC Wainwright & Co. Reiterates Buy on Assertio Holdings, Maintains $4 Price Target
Promising Buy Rating for Assertio Therapeutics Backed by Positive ROLVEDON Trial Results and Market Potential